id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-4853-0006,FDA,FDA-2017-N-4853,Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar or Interchangeable Biosimilar Applicant,Notice,Notice of Publication,2024-07-11T04:00:00Z,2024,7,2024-07-11T04:00:00Z,,2024-07-11T12:32:43Z,2024-15237,0,0,09000064865e7e65
FDA-2017-N-4853-0005,FDA,FDA-2017-N-4853,Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar or Interchangeable Biosimilar Applicant,Notice,General Notice,2023-03-07T05:00:00Z,2023,3,2023-03-07T05:00:00Z,,2023-03-07T14:10:47Z,2023-04583,0,0,090000648576d48a
FDA-2017-N-4853-0004,FDA,FDA-2017-N-4853,Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar or Interchangeable Biosimilar Applicant,Notice,Notice of Publication,2022-02-10T05:00:00Z,2022,2,2022-02-10T05:00:00Z,,2022-02-10T14:21:09Z,2022-02799,0,0,0900006484f696c0
FDA-2017-N-4853-0003,FDA,FDA-2017-N-4853,Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar Applicant,Notice,General Notice,2018-09-12T04:00:00Z,2018,9,2018-09-12T04:00:00Z,,2018-09-12T13:44:59Z,2018-19811,0,0,09000064836df572
FDA-2017-N-4853-0002,FDA,FDA-2017-N-4853,Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar Applicant,Notice,General Notice,2017-12-04T05:00:00Z,2017,12,2017-12-04T05:00:00Z,,2017-12-04T15:24:30Z,2017-26013,0,0,0900006482cd3be6
FDA-2017-N-4853-0001,FDA,FDA-2017-N-4853,Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar Applicant,Notice,Notice of Publication,2017-11-20T05:00:00Z,2017,11,2017-11-20T05:00:00Z,,2017-11-20T15:07:06Z,2017-25070,0,0,0900006482c91a12